lactic acid has been researched along with caffeic acid in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 2 (50.00) | 2.80 |
Authors | Studies |
---|---|
Brautigan, DL; Haaga, JR; Kubicka, E; Leitinger, N; Liu, W; Serbulea, V; Wilkins, LR; Wu, H; Yarmohammadi, H | 1 |
Arasoğlu, T; Derman, S | 1 |
Diao, A; Guo, B; Guo, Z; Hao, L; Li, L; Li, Y; Liu, Z; Yang, Y; Zhao, Q | 1 |
Bellosta, S; Castiglioni, S; Cilurzo, F; Magri, G; Procacci, P; Puoci, F; Rizzello, L; Rossi, C; Sartori, P; Scarpa, E; Selmin, F; Tolva, V | 1 |
4 other study(ies) available for lactic acid and caffeic acid
Article | Year |
---|---|
Cinnamic Acid Derivatives Enhance the Efficacy of Transarterial Embolization in a Rat Model of Hepatocellular Carcinoma.
Topics: Acrylates; Animals; Caffeic Acids; Cell Line, Tumor; Coumaric Acids; Disease Models, Animal; Embolization, Therapeutic; Female; Lactic Acid; Liver Neoplasms; Liver Neoplasms, Experimental; Male; Neoplasm Transplantation; Rats; Treatment Outcome; Tumor Burden | 2017 |
Assessment of the Antigenotoxic Activity of Poly(d,l-lactic- co-glycolic acid) Nanoparticles Loaded with Caffeic Acid Phenethyl Ester Using the Ames Salmonella/Microsome Assay.
Topics: Antimutagenic Agents; Caffeic Acids; Esters; Lactic Acid; Microsomes; Mutagens; Mutation; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Salmonella | 2018 |
The novel prolyl hydroxylase-2 inhibitor caffeic acid upregulates hypoxia inducible factor and protects against hypoxia.
Topics: Animals; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Hypoxia-Inducible Factor-Proline Dioxygenases; Lactate Dehydrogenases; Lactic Acid; Malondialdehyde; Mice; Neuroblastoma; Neuroprotective Agents; Procollagen-Proline Dioxygenase; Prolyl-Hydroxylase Inhibitors; RNA, Messenger; Transcription Factors; Vascular Endothelial Growth Factor A | 2022 |
Caffeic Acid-Grafted PLGA as a Novel Material for the Design of Fluvastatin-Eluting Nanoparticles for the Prevention of Neointimal Hyperplasia.
Topics: Drug Carriers; Endothelial Cells; Fluvastatin; Humans; Hyperplasia; Lactic Acid; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2022 |